Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Enanta Pharmaceuticals (ENTA) Times Interest Earned (2016 - 2025)

Enanta Pharmaceuticals' Times Interest Earned history spans 9 years, with the latest figure at -$3.65 for Q4 2025.

  • For Q4 2025, Times Interest Earned rose 69.58% year-over-year to -$3.65; the TTM value through Dec 2025 reached -$8.3, up 28.84%, while the annual FY2025 figure was -$11.11, 0.11% changed from the prior year.
  • Times Interest Earned reached -$3.65 in Q4 2025 per ENTA's latest filing, up from -$7.7 in the prior quarter.
  • In the past five years, Times Interest Earned ranged from a high of -$3.65 in Q4 2025 to a low of -$18.38 in Q2 2023.
  • Average Times Interest Earned over 3 years is -$11.12, with a median of -$11.57 recorded in 2024.
  • Peak YoY movement for Times Interest Earned: fell 18.36% in 2024, then skyrocketed 69.58% in 2025.
  • A 3-year view of Times Interest Earned shows it stood at -$10.14 in 2023, then fell by 18.36% to -$12.0 in 2024, then surged by 69.58% to -$3.65 in 2025.
  • Per Business Quant, the three most recent readings for ENTA's Times Interest Earned are -$3.65 (Q4 2025), -$7.7 (Q3 2025), and -$11.68 (Q2 2025).